Skip to content

Bacchus Vascular, Inc.

United StatesFDA applicant, unverified

Devices
10
FDA recalls
2

At a glance

Counted by deviCERTS from registry records

Market reach

United States
FDA recalls

What Bacchus Vascular, Inc. makes

Bacchus Vascular, Inc. manufactures peripheral infusion systems and thrombectomy catheters for vascular procedures. The Trellis and Trellis-Plus infusion systems include catheters with varying lengths (10 cm, 20 cm, 100 cm, and 140 cm) designed for drug delivery or fluid infusion in peripheral vessels. Thrombectomy catheters, such as the Bacchus Thrombectomy Catheter (BTC) and Solera Magnum/Solera Plus models (55 cm and 110 cm), are intended for clot removal in vascular treatments. Additional infusion systems like Trellis-6, Trellis-8, and SpiralFuse cater to peripheral vascular access needs.

These devices are classified as Class II under FDA regulations and are supported by 510(k) clearances. The company’s products are listed in the FDA’s 510(k) registry. Bacchus Vascular, Inc. is based in the United States.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue10

Newest first, rows 1-10 of 10

FDA recalls2

Recalls are matched to the firm by name. FDA recall data as of 22 Oct 2026.

FDA recall records list 2 recalls initiated by Bacchus Vascular, Inc., initiated on 2003-11-24. By recorded status: 2 terminated. The reasons filed fall into these groups: mechanical integrity. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

  • 2003

    • 24 Nov 2003 Z-0816-04 Unclassified (pre-2012) Terminated The device has the potential for fractures at the distal end during use. Distribution: Product was released for distribution to 131 consignees in US. The firm identified 18 foreign distributors that received…
      Full distribution text Product was released for distribution to 131 consignees in US. The firm identified 18 foreign distributors that received recall products. The product received nationwide distribution. The firm has also distributed products into international channels through distributors. Countries include: NETHERLANDS, Argentina, ISRAEL, Czech Republic, ARGENTINA, GERMANY, AUSTRIA, SWITZERLAND, IRELAND, HONG KONG, GERMANY, GREECE, Belgium, SOUTH AFRICA, UK, ITALY, UK, and NORWAY There is no known U. S. Government or Canadian distribution.
      Submission number: K021958
    • 24 Nov 2003 Z-0817-04 Unclassified (pre-2012) Terminated The device has the potential for fractures at the distal end during use. Distribution: Product was released for distribution to 131 consignees in US. The firm identified 18 foreign distributors that received…
      Full distribution text Product was released for distribution to 131 consignees in US. The firm identified 18 foreign distributors that received recall products. The product received nationwide distribution. The firm has also distributed products into international channels through distributors. Countries include: NETHERLANDS, Argentina, ISRAEL, Czech Republic, ARGENTINA, GERMANY, AUSTRIA, SWITZERLAND, IRELAND, HONG KONG, GERMANY, GREECE, Belgium, SOUTH AFRICA, UK, ITALY, UK, and NORWAY There is no known U. S. Government or Canadian distribution.
      Submission number: K023514

Frequently asked questions

How many devices does Bacchus Vascular, Inc. have in the registry?

The registry currently lists 10 devices for Bacchus Vascular, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Bacchus Vascular, Inc.'s devices?

Among its 10 most recently registered devices, Bacchus Vascular, Inc. has devices listed in FDA 510(k) (10 devices).

What risk classes do Bacchus Vascular, Inc.'s devices fall under?

Among its 10 most recently registered devices, the classes recorded for Bacchus Vascular, Inc.'s devices are Class II. Each device page shows its own class and authorisation.

Are there FDA recall records for Bacchus Vascular, Inc.?

FDA recall records list 2 recalls initiated by Bacchus Vascular, Inc., the most recent initiated on 24 Nov 2003. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What are the newest devices from Bacchus Vascular, Inc. in the registry?

The most recently registered devices listed for Bacchus Vascular, Inc. include TRELLIS INFUSION SYSTEM (10CM INFUSION LENGTH); TRELLIS INFUSION SYSTEM (20CM INFUSION LENGTH), TRELLIS-6 PERIPHERAL INFUSION SYSTEM (140CM CATHETER LENGTH 10CM INFUSION LENGTH), BACCHUS THROMBECTOMY CATHETER (BTC), MODEL BTC-0755 and Trellis Reserve Infusion System.

Generated automatically from registry data and not verified by a human reviewer.